Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine

Jason S. Richardson, Michel K. Yao, Kaylie N. Tran et al. · 2009

Read Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine by Jason S. Richardson, Michel K. Yao, Kaylie N. Tran et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005308.txt.

Description

Ebola virus spreads by direct contact with body fluids and can kill up to ninety percent of those infected. A vaccine based on a disabled adenovirus was already in early human testing. Richardson and colleagues tested an improved version in PLOS ONE in 2009.

The improved adenovirus-based vaccine gave enhanced protection against Ebola in their tests. Better protection from a vaccine platform already known to be safe is valuable progress. Outbreak response needs vaccines that work fast and strongly, and this work moves that goal closer. A strong vaccine for this virus must work in the field, where cold chains fail and care is far off. So each gain in strength gives outbreak teams a tool they can trust more.

Catalog record

CREATORJason S. Richardson, Michel K. Yao, Kaylie N. Tran et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005308

Browse the full library · About the Tower of Babel